Phosphatidylethanol compared with other blood tests as a biomarker of moderate alcohol consumption in healthy volunteers: A prospective randomized study

Alcohol and Alcoholism

Volumn 50, Issue 4, 2015, Pages 399-406

  Kechagias, Stergios ^a   Dernroth, Dženeta Nezirević ^a   Blomgren, Anders ^b   Hansson, Therese ^b   Isaksson, Anders ^b   Walther, Lisa ^b   Kronstrand, Robert ^a,c   Kågedal, Bertil ^a   Nystrom, Fredrik H ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c National Board of Forensic Medicine   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE; PHOSPHATIDYLETHANOL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CARBOHYDRATE-DEFICIENT TRANSFERRIN; GLYCEROPHOSPHOLIPID; TRANSFERRIN;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MEAN CORPUSCULAR VOLUME; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; TANDEM MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; BLOOD; DRINKING BEHAVIOR; PROCEDURES; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE;

ADULT; ALANINE TRANSAMINASE; ALCOHOL ABSTINENCE; ALCOHOL DRINKING; ASPARTATE AMINOTRANSFERASES; BIOMARKERS; ERYTHROCYTE INDICES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLYCEROPHOSPHOLIPIDS; HEALTHY VOLUNTEERS; HUMANS; MALE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TRANSFERRIN;

EID: 84937400539     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agv038     Document Type: Article

References (28)

1. Andreasson S, Allebeck P. (2005) Alkohol och hälsa. En kunskapsöversikt om alkoholens positiva och negativa effekter på vår hälsa. Alcohol and health. Swedish National Institute of Public Health. Report 2005:11. Available at http:// www.folkhalsomyndigheten.se/pagefiles/12073/r200511alkoholhalsa0601.pdf. Accessed April 9, 2015.
2. Aradottir S, Asanovska G, Gjerss S, et al. (2006) Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcoholdependent patients. Alcohol Alcohol 41:431-7.
3. Arthur MJ, Lee A, Wright R. (1984) Sex-differences in the metabolism of ethanol and acetaldehyde in normal subjects. Clin Sci (Lond) 67:397-401.
4. Bajunirwe F, Haberer JE, Boum Y II, et al. (2014) Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in Southwestern Uganda. PLoS One 9:e113152. doi: 10.1371/journal.pone.0113152.eCollection2014.
5. Bergman S, Symeonidou S, Andersson ML, et al. (2013) Alcohol consumption is associated with lower self-reported disease activity and better health-related quality of life in female rheumatoid arthritis patients in Sweden: data from BARFOT, a multicenter study on early RA. BMC Musculoskelet Disord 14:218.
6. Bergström JP, Helander A. (2008) Clinical characteristics of carbohydratedeficient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers. Alcohol Alcohol 43:436-41.
7. Borowsky SA, Strome S, Lott E. (1981) Continued heavy drinking and survival in alcoholic cirrhotics. Gastroenterology 80:1405-9.
8. Bush K, Kivlahan DR, McDonell MB, et al. (1998) The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Int Med 158:1789-95.
9. Fields DA, Goran MI, McCrory MA. (2002) Body-composition assessment via air-displacement plethysmography in adults and children: a review. Am J Clin Nutr 75:453-67.
10. Gnann H, Weinmann W, Engelmann C, et al. (2009) Selective detection of phosphatidylethanol homologues in blood as biomarkers for alcohol consumption by LC-ESI-MS/MS. J Mass Spectrom 44:1293-9.
11. GnannH, Engelmann C, Skopp G, et al. (2010) Identification of 48 homologues of phosphatidylethanol in blood by LC-ESI-MS/MS. Anal Bioanal Chem 396:2415-23.
12. Gnann H, Weinmann W, Thierauf A. (2012) Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days. Alcohol Clin Exp Res 36:1507-11.
13. Hartmann S, Aradottir S, Graf M, et al. (2007) Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin. Addict Biol 12:81-4.
14. Helander A, Zheng Y. (2009) Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. Clin Chem 55:1395-405.
15. Helander A, Husa A, Jeppsson JO. (2003) Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem 49:1881-90.
16. Isaksson A, Walther L, Hansson T, et al. (2011) Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse. Drug Test Anal 3:195-200.
17. Jain J, Evans JL, Briceño A, et al. (2014) Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users. Alcohol Alcohol 49:520-4.
18. Kronstrand R, Brinkhagen L, Nystrom FH. (2012) Ethyl glucuronide in hair after daily consumption of 16 or 32 g of ethanol for 3 months. Forensic Sci Int 215:51-5.
19. Luca A, García-Pagán JC, Bosch J, et al. (1997) Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 112:1284-9.
20. Marques P, Hansson T, Isaksson A, et al. (2011) Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program. Traffic Inj Prev 12:136-41.
21. Nalesso A, Viel G, Cecchetto G, et al. (2011) Quantitative profiling of phosphatidylethanol molecular species in human blood by liquid chromatography high resolution mass spectrometry. J Chromatogr A 1218:8423-31.
22. Nichols M, Scarborough P, Allender S, et al. (2012) What is the optimal level of population alcohol consumption for chronic disease prevention in England? Modelling the impact of changes in average consumption levels. BMJ Open 2. pii: e000957.
23. Schellenberg F, Schwan R, Mennetrey L, et al. (2005) Dose-effect relation between daily ethanol intake in the range 0-70 grams and %CDT value: validation of a cut-off value. Alcohol Alcohol 40:531-4.
24. Varga A, Hansson P, Lundqvist C, et al. (1998) Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers. Alcohol Clin Exp Res 22:1832-7.
25. Weykamp C, Franck P, Klein J, et al. (2014) Harmonisation of seven common enzyme results through EQA. Clin Chem Lab Med 52: 1549-55.
26. Wurst FM, Vogel R, Jachau K, et al. (2003) Ethyl glucuronide discloses recent covert alcohol use not detected by standard testing in forensic psychiatric inpatients. Alcohol Clin Exp Res 27:471-6.
27. Wurst FM, Alexson S, Wolfersdorf M, et al. (2004) Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self reported-ethanol intake. Alcohol Alcohol 39:33-8.
28. Zheng Y, Beck O, Helander A. (2011) Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood. Clin Chim Acta 412:1428-35.